La pharmacogénétique comme aide précieuse au monitoring thérapeutique : l’expérience acquise aux Cliniques universitaires Saint-Luc avec les médicaments immunosuppresseurs utilisés en transplantation rénale

Haufroid, Vincent;De Meyer, Martine;Wallemacq, Pierre;Mourad, Michel
(2015) Louvain médical — Vol. 134, n° 7, p. 373-378 (2015)

Files

2015_Haufroid_LM_1347_373-378.pdf
  • Restricted Access
  • Adobe PDF
  • 255.85 KB

Details

Authors
  • Author
  • De Meyer, MartineUCLouvain
    Author
  • Wallemacq, PierreUCLouvain
    Author
  • Mourad, MichelUCLouvain
    Author
Abstract
(en) Pharmacogenetics as a tool to improve therapeutic drug monitoring: experience at Cliniques universitaires Saint-Luc with administering immunosuppressive drugs to renal transplantation patients] Despite being highly effective, certain drugs exhibit considerable side-effects, thus being characterized by a relatively narrow therapeutic index. For this specific reason, it is at times required to regularly check these drugs’ blood concentration in order to find the finest compromise between optimal therapeutic efficacy and reduced toxicity. Therapeutic drug monitoring (tDM) is applied to immunosuppressants used in solid organ transplantation. Compared to conventional tDM, a first improvement consists in understanding the origin of interindividual variability at the pharmacokinetic level. This would allow for better anticipating this variability by proposing individualized dosages according to each patient's genetic characteristics. Another improvement, complementary to the first, consists in directly measuring the drug’s active biological dose in target tissues, such as lymphocytes in our case, while simultaneously studying genetic and other factors impacting this parameter. As a complement to conventional tDM, pharmacogenetics is instrumental in enabling a better individualization of drug therapy.
Affiliations

Citations

Haufroid, V., De Meyer, M., Wallemacq, P., & Mourad, M. (2015). La pharmacogénétique comme aide précieuse au monitoring thérapeutique : l’expérience acquise aux Cliniques universitaires Saint-Luc avec les médicaments immunosuppresseurs utilisés en transplantation rénale. Louvain médical, 134(7), 373-378. https://hdl.handle.net/2078.5/51975 (Original work published 2015)